CymaBay Therapeutics, Inc. CBAY
32.48 0.00 0.00%
At close · Mar 21
52-week range unavailable
- Open
- 32.49
- Prev close
- 32.48
- Mkt cap
- 3.73B
- Vol
- 8.35M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 32.48
- High
- 32.50
- Forward P/E
- -30.93
- Beta
- 0.32
- Short ratio
- 0.84
- Inst. own
- 103.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 28, 2024
- 50-d avg
- 29.11
- 200-d avg
- 19.07
- 1y target
- 32.50
1D chart
Chart tools
Chart is warming up
The one-day price history for CBAY has not been loaded yet. Try again in a moment.
Altman Z-Score
12.91 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -23.9×
P/S 80.7×
P/B 8.6×
P/FCF -34.4×
EV/EBITDA -28.2×
EV/Sales 77.8×
FCF Yield -2.9%
Gross Margin 97.8%
Operating Margin -327.2%
Net Margin -339.1%
ROE -36.1%
ROIC -24.9%
ROA -24.2%
Revenue 0.0%
Operating Income -9.2%
EPS (diluted) 26.7%
Free Cash Flow 13.4%
Current Ratio 11.0×
Quick Ratio 11.0×
Debt / Equity 0.4×
Net Debt / EBITDA 1.1×
Interest Coverage -5.4×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31